Prognostic factors on the GVHD-free and relapse-free survival after adult allo-HSCT for AML and MDS

Goichi Yoshimoto

Presentation information

Oral Session

Oral Session 2-14A GVHD: Clinic

Sat. Oct 13, 2018 4:00 PM - 5:00 PM No.14 (Osaka International Convention Center, 8F 801-2)

Chair: Yoshihiro Inamoto (National Cancer Center Hospital, Japan)

[OS2-14A-5] Prognostic factors on the GVHD-free and relapse-free survival after adult allo-HSCT for AML and MDS

Goichi Yoshimoto¹, Yasuo Mori¹, Akihiko Numata¹, Koji Kato¹, Takahiro Maeda², Katsuto Takenaka¹, Toshihiro Miyamoto¹, Koichi Akashi^1,2 (1.Hematology, Oncology and Cardiovascular medicine, Kyushu University Hospital, Fukuoka, 2.Center for Cellular and Molecular Medicine, Kyushu University Hospital, Fukuoka)

Abstract password authentication.
Password is written on a program and abstract book.